Laura Rubbia‐Brandt

University of Geneva, University Hospital of Geneva

Papers

2

Total Citations

140

H-Index

2

About

Dr. Laura Rubbia‐Brandt is a leading figure in hepatobiliary and pancreatic surgery, with a research focus on advancing minimally invasive techniques for liver cancer treatment. Her work has significantly shaped the shift from traditional open surgery to robotic and laparoscopic approaches, improving patient outcomes. In a landmark 2015 case–control study (86 citations), she demonstrated that minimally invasive surgery offers comparable oncologic efficacy to percutaneous radio frequency ablation for single small hepatocellular carcinomas (≤3 cm), establishing a less invasive surgical standard. Expanding on this, her 2017 case-matched comparison (54 citations) provided critical evidence that robotic liver resections are a safe and effective alternative to open procedures, with reduced blood loss and shorter hospital stays. Dr. Rubbia‐Brandt’s contributions have been pivotal in validating the role of robotics in complex liver surgery, directly influencing clinical guidelines and training paradigms. Her work, cited over 140 times in these key studies alone, continues to drive innovation in surgical oncology, making her a respected authority in the field.

Research Focus

Key Achievements

2
H-Index
2
Papers
140
Total Citations
70
Avg Citations/Paper
🏆 Most Cited Paper
Minimally invasive surgery versus percutaneous radio frequency ablation for the treatment of single small (≤3 cm) hepatocellular carcinoma: a case–control study
86 citations · 2015
📈 Most Prolific Year: 2015 (1 Papers)
🤝 Key Collaborators: 15
🏛 Institutions: University of Geneva, University Hospital of Geneva

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 16 days ago